Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer

Johannes Wohlrab1 Martin Luther University Halle-Wittenberg, Department of Dermatology and Venereology, Halle (Saale), GermanyCorrespondence[email protected]

Nikola Bangemann2 Interdisciplinary Breast Centre, University Hospital Charité Berlin, Campus Benjamin Franklin, Berlin, Germany

Anke Kleine-Tebbe3 Breast Centre DRK Hospital, Berlin, Germany

Marc Thill4 Breast Centre University of Lübeck, Department of Gynaecology and Obstetrics, Lübeck, Germany;5 Department of Gynaecology and Obstetrics, Agaplesion Markus Hospital, Frankfurt am Main, Germany

Sherko Kümmel6 Breast Centre and Clinic of Senology, Hospital Essen-Mitte, Essen, Germany

Eva-Maria Grischke7 Breast Centre University of Tübingen, Department of Gynaecology, Tübingen, Germany

Rainer Richter8 L’Oréal, Deutschland GmbH, Düsseldorf, Germany

Sophie Seite9 La Roche-Posay, Dermatological Laboratories, Asnières, France

Diana Lüftner10 University Hospital Charité Berlin, Campus Benjamin Franklin, Department of Hematology, Oncology and Tumour Immunology, Berlin, Germany

show all

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer

Articles from other publishers (4)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer

Citations (4)

Articles from other publishers (4)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date